MedTrace Logo

Effect of Respiratory Exerciser on Pulmonary Functions of COVID-19 Patients

NCT04826731 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2022-01-31

Study results available
· View outcomes & findings →

Summary

COVID-19 infection is the cause of the current pandemic, responsible for loss of life and disability at a rate unseen before. Among survivors, the infection may cause lasting damage, such as permanent loss of lung function.

This study aims to investigate if pulmonary rehabilitation done via supportive devices may reduce or prevent lung function injury. Patients will be chosen among COVID-19 patients who require hospitalization. Patients then will be divided into two groups, those who had used said devices, and compare them to those who had not used them for any reason. After a month, two groups will be evaluated by respiratory function tests, which are expected to provide the results required for a proper comparison.

Pulmonary rehabilitation provided by the supportive devices is expected to either lessen or eliminate a loss of pulmonary function over time, compared to the group who did not use them.

Conditions

  • Covid19
  • Respiratory Function Loss
  • Coronavirus Infection
  • Pneumonia, Viral

Interventions

OTHER

Incentive Spirometer/Respiratory Exerciser

A patient is considered acceptable for the "Incentive Spirometer Group" if the patient can use an incentive spirometer and/or a respiratory exerciser at least four times per day. A pulmonary medicine specialist will confirm the proper usage of the device.

Sponsors & Collaborators

  • Diskapi Yildirim Beyazit Education and Research Hospital

    lead OTHER_GOV

Principal Investigators

  • Bahar Kurt, Professor · Dışkapı Yıldırım Beyazıt Training and Research Hospital Pulmonary Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2021-06-01
Completion
2021-07-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04826731 on ClinicalTrials.gov